Bank of America
ACUR

Bank of America’s Acura Pharmaceuticals ACUR Stock Holding History

Bank of America’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed – – 7546
2016
Q4 		$0 Sell
1
-850
-100% -$889 ﹤0.01% 7615
2016
Q3 		$1K Buy
851
+605
+246% +$1.07K ﹤0.01% 7047
2016
Q2 		$0 Buy
246
+6
+3% +$15 ﹤0.01% 7634
2016
Q1 		$1K Hold
240
– – ﹤0.01% 6921
2015
Q4 		$1K Hold
240
– – ﹤0.01% 7239
2015
Q3 		$1K Sell
240
-180
-43% -$612 ﹤0.01% 7106
2015
Q2 		$2K Hold
420
– – ﹤0.01% 7081
2015
Q1 		$2K Hold
420
– – ﹤0.01% 6732
2014
Q4 		$1K Sell
420
-2,291
-85% -$6.34K ﹤0.01% 7599
2014
Q3 		$11K Buy
2,711
+2,291
+545% +$10.8K ﹤0.01% 7306
2014
Q2 		$2K Hold
420
– – ﹤0.01% 7865
2014
Q1 		$3K Sell
420
-63
-13% -$547 ﹤0.01% 7501
2013
Q4 		$5K Buy
483
+243
+101% +$2.05K ﹤0.01% 7484
2013
Q3 		$2K Sell
240
-4,462
-95% -$39.5K ﹤0.01% 7669
2013
Q2 		$44K Buy
+4,702
New +$53.1K ﹤0.01% 6646

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Bank of America's ACUR Position: Q1 2017 in Review

Bank of America sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 1 share.

Bank of America first reported a position in ACUR in Q2 2013 and held it in 15 quarters. The position peaked at $44K in Q2 2013. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

  • Bank of America reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Bank of America sold 1 Acura Pharmaceuticals share in Q1 2017.
  • Bank of America first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Bank of America's Acura Pharmaceuticals position peaked at $44K in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Bank of America's 13F filing for Q1 2017, filed 15 May 2017.